Krishnan Viswanadhan

Chief Corp Dev & Strategy, Agios Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Apr 2, 2026

Companies

Agios Pharmaceuticals, Inc.Chief Corp Dev & Strategy −$0.2M

Trades

AGIO Sold 2,959 shares at $34.71 · planned $0.1M Apr 2

AGIO Sold 2,959 shares at $27.80 · planned $0.1M Mar 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.